SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Dupont E I De Nemours & Co – ‘10-Q’ for 9/30/16 – ‘EX-32.2’

On:  Tuesday, 10/25/16, at 1:40pm ET   ·   For:  9/30/16   ·   Accession #:  30554-16-156   ·   File #:  1-00815

Previous ‘10-Q’:  ‘10-Q’ on 7/26/16 for 6/30/16   ·   Next:  ‘10-Q’ on 4/25/17 for 3/31/17   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/25/16  Dupont E I De Nemours & Co        10-Q        9/30/16   84:10M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    704K 
 2: EX-12       Statement re: Computation of Ratios                 HTML     32K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
13: R1          Document and Entity Information                     HTML     43K 
14: R2          Consolidated Income Statements                      HTML     92K 
15: R3          Consolidated Statements of Comprehensive Income     HTML     90K 
16: R4          Condensed Consolidated Balance Sheets               HTML    122K 
17: R5          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
18: R6          Condensed Consolidated Statements of Cash Flows     HTML    109K 
19: R7          Summary of Significant Accounting Policies          HTML     41K 
20: R8          Proposed Merger with Dow Chemical                   HTML     32K 
21: R9          Divestitures and Other Transactions                 HTML     77K 
22: R10         Employee Separation / Asset Related Charges, Net    HTML     83K 
23: R11         Other (Loss) Income, Net                            HTML     83K 
24: R12         Provision for Income Taxes                          HTML     29K 
25: R13         Earnings Per Share of Common Stock                  HTML     68K 
26: R14         Inventories                                         HTML     36K 
27: R15         Other Intangible Assets                             HTML     81K 
28: R16         Short-Term and Long-Term Borrowings                 HTML     33K 
29: R17         Commitments and Contingent Liabilities              HTML     81K 
30: R18         Stockholders' Equity                                HTML    269K 
31: R19         Financial Instruments                               HTML    195K 
32: R20         Long-Term Employee Benefits                         HTML     87K 
33: R21         Segment Information                                 HTML    158K 
34: R22         Summary of Significant Accounting Policies Summary  HTML     41K 
                of Significant Accounting Policies (Policies)                    
35: R23         Divestitures and Other Transactions Divestitures    HTML     67K 
                and Other Transactions (Tables)                                  
36: R24         Employee Separation / Asset Related Charges, Net    HTML     74K 
                (Tables)                                                         
37: R25         Other (Loss) Income, Net (Tables)                   HTML     84K 
38: R26         Earnings Per Share of Common Stock (Tables)         HTML     68K 
39: R27         Inventories (Tables)                                HTML     36K 
40: R28         Other Intangible Assets (Tables)                    HTML     78K 
41: R29         Commitments and Contingent Liabilities (Tables)     HTML     52K 
42: R30         Stockholders' Equity (Tables)                       HTML    257K 
43: R31         Financial Instruments (Tables)                      HTML    181K 
44: R32         Long-Term Employee Benefits (Tables)                HTML     82K 
45: R33         Segment Information (Tables)                        HTML    157K 
46: R34         Summary of Significant Accounting Policies Recent   HTML     32K 
                Accounting Pronouncements (Details)                              
47: R35         Proposed Merger with Dow Chemical (Narrative)       HTML     26K 
                (Details)                                                        
48: R36         Divestitures and Other Transactions (Narrative)     HTML    103K 
                (Details)                                                        
49: R37         Divestitures and Other Transactions (Schedule of    HTML     59K 
                results of operations from discontinued                          
                operations) (Details)                                            
50: R38         Divestitures and Other Transactions (Schedule of    HTML     32K 
                cash flow information of discontinued operations)                
                (Details)                                                        
51: R39         Employee Separation / Asset Related Charges, Net    HTML     35K 
                (La Porte) (Narrative) (Details)                                 
52: R40         Employee Separation / Asset Related Charges, Net    HTML     76K 
                (2016 Restructuring Program schedule )(Details)                  
53: R41         Employee Separation / Asset Related Charges, Net    HTML     57K 
                (2014 Restructuring Program schedule) (Details)                  
54: R42         Employee Separation / Asset Related Charges, Net    HTML     35K 
                (Narrative) (Details)                                            
55: R43         Employee Separation / Asset Related Charges, Net    HTML     34K 
                (Asset Impairment) (Narrative) (Details)                         
56: R44         Other (Loss) Income, Net (Schedule of Other         HTML     55K 
                Income) (Details)                                                
57: R45         Other (Loss) Income, Net (Schedule of Foreign       HTML     39K 
                Exchange Gain (Loss)) (Details)                                  
58: R46         Provision for Income Taxes (Details)                HTML     29K 
59: R47         Earnings Per Share of Common Stock (Earnings Per    HTML     49K 
                Share of Common Stock Reconciliation) (Details)                  
60: R48         Earnings Per Share of Common Stock (Schedule of     HTML     30K 
                Average Number of Antidilutive Stock Options)                    
                (Details)                                                        
61: R49         Inventories (Details)                               HTML     37K 
62: R50         Other Intangible Assets (Schedule of Other          HTML     71K 
                Intangible Assets) (Details)                                     
63: R51         Other Intangible Assets (Narrative) (Details)       HTML     45K 
64: R52         Short-Term and Long-Term Borrowings (Details)       HTML     73K 
65: R53         Commitments and Contingent Liabilities              HTML     60K 
                (Guarantees) (Details)                                           
66: R54         Commitments and Contingent Liabilities              HTML     97K 
                (Litigation) (Narrative) (Details)                               
67: R55         Commitments and Contingent Liabilities              HTML     38K 
                (Environmental) (Narrative) (Details)                            
68: R56         Stockholders' Equity (Share Repurchase Program)     HTML     54K 
                (Narrative) (Details)                                            
69: R57         Stockholders' Equity (Noncontrolling Interest)      HTML     30K 
                (Narrative) (Details)                                            
70: R58         Stockholders' Equity (Schedule of Other             HTML    197K 
                Comprehensive Income) (Details)                                  
71: R59         Stockholder's Equity (Schedule of Accumulated       HTML     81K 
                Other Comprehensive Loss) (Details)                              
72: R60         Financial Instruments (Schedule of Cash, Cash       HTML     65K 
                Equivalents and Marketable Securities) (Details)                 
73: R61         Financial Instruments (Debt) (Narrative) (Details)  HTML     26K 
74: R62         Financial Instruments (Notional Amounts of          HTML     34K 
                Derivatives) (Details)                                           
75: R63         Financial Instruments (Effect of Cash Flows Hedges  HTML     37K 
                on Accumulated Other Comprehensive Income (Loss))                
                (Details)                                                        
76: R64         Financial Instruments (Schedule of the Fair Value   HTML     52K 
                of Derivative Instruments) (Details)                             
77: R65         Financial Instruments (Effect of Derivative         HTML     67K 
                Instruments) (Details)                                           
78: R66         Long-Term Employee Benefits (Schedules of Net       HTML     80K 
                Periodic Benefit Cost) (Details)                                 
79: R67         Segment Information (Schedule of Segment            HTML     51K 
                Information) (Details)                                           
80: R68         Segment Information (Reconciliation to              HTML     77K 
                Consolidated Income Statements) (Details)                        
81: R69         Segment Information (Significant Pre-tax (charges)  HTML    128K 
                benefits not included in Segment Operating                       
                Earnings) (Details)                                              
83: XML         IDEA XML File -- Filing Summary                      XML    156K 
82: EXCEL       IDEA Workbook of Financial Reports                  XLSX    103K 
 7: EX-101.INS  XBRL Instance -- dd-20160930                         XML   3.95M 
 9: EX-101.CAL  XBRL Calculations -- dd-20160930_cal                 XML    261K 
10: EX-101.DEF  XBRL Definitions -- dd-20160930_def                  XML   1.10M 
11: EX-101.LAB  XBRL Labels -- dd-20160930_lab                       XML   1.88M 
12: EX-101.PRE  XBRL Presentations -- dd-20160930_pre                XML   1.20M 
 8: EX-101.SCH  XBRL Schema -- dd-20160930                           XSD    219K 
84: ZIP         XBRL Zipped Folder -- 0000030554-16-000156-xbrl      Zip    322K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 32.2
 
Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended September 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Nicholas C. Fanandakis, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Chief Financial Officer

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/25/168-K
For Period end:9/30/16
 List all Filings 
Top
Filing Submission 0000030554-16-000156   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 3:00:05.1pm ET